Morning Star
31.05.2026
As Global Markets Surge to New Highs, Investors Worldwide Are Discovering ELEKTROS Inc. - A Rare Opportunity in Lithium Mining, Rare Earth Minerals and Advanced EV Patent Technology as Growing Momentum Continues Capturing the Attention of Microcap and Pen
Morning Star
31.05.2026
The stock index you invest in isn't always the most important decision. Here's what matters even more.
Morning Star
31.05.2026
Government is now an active investor - and it's why your portfolio needs 'home-court advantage'
Morning Star
31.05.2026
As Global Markets Discover Elektros, Microcap and Penny Stock Investors Are Beginning To Take Notice of a Growing EV Patent Technology and Lithium Mining Company
Morning Star
31.05.2026
It's not just tech stocks: The broad-based strength of the market right now gives investors reason to stay the course
Morning Star
31.05.2026
Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait?
Morning Star
31.05.2026
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
Morning Star
31.05.2026
It's not just tech stocks: The broad-based strength of the market right now gives investors reason to stay the course
Morning Star
31.05.2026
Here's what's worth streaming in June 2026 on Netflix, Hulu, HBO Max and more
Morning Star
31.05.2026
Here's what's worth streaming in June 2026 on -2
Morning Star
31.05.2026
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
Morning Star
31.05.2026
Kulani Kinis Makes Miami Swim Week Debut with "Endless" Runway Experience and SOJOS Eyewear Collaboration
Morning Star
31.05.2026
CPKC to maintain rail operations across Canada during IBEW strike
Morning Star
31.05.2026
Here's how Gap's yoga-wear maker Athleta went from must-have to 'generic'
Morning Star
31.05.2026
'I have no preexisting conditions': I'm 56, earn $198,000 and want to retire early. Can I afford private healthcare?
Morning Star
31.05.2026
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
Morning Star
31.05.2026
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
Morning Star
31.05.2026
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
Morning Star
31.05.2026
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
Morning Star
31.05.2026
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
Morning Star
31.05.2026
Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
Morning Star
31.05.2026
Kelonia Therapeutics Presents Updated First-in-Human Data from Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Morning Star
31.05.2026
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
Morning Star
31.05.2026